Offer - Urjas Oil for just ₹ 1 X
Carvistar 3.125 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of High BP. Other than this, Carvistar 3.125 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Carvistar 3.125 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Carvistar 3.125 Tablet as well, which are listed below. Normally, these side effects of Carvistar 3.125 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Carvistar 3.125 Tablet's effect is Moderate during pregnancy and Safe for lactating mothers. In addition, Carvistar 3.125 Tablet's effects on the liver, heart and kidney are discussed below in the Carvistar 3.125 Tablet related warnings section.
Carvistar 3.125 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) are examples of such conditions. Other conditions have been mentioned below in the Carvistar 3.125 Tablet contraindications section.
Drug interactions for Carvistar 3.125 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Carvistar 3.125 Tablet is considered not safe while driving, and is not addictive.
Carvistar 3.125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Carvistar 3.125 Tablet safe for pregnant women?
Carvistar can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Carvistar right away. Take your doctor's advice before taking it again.
Is the use of Carvistar 3.125 Tablet safe during breastfeeding?
Carvistar is completely safe for breastfeeding women.
What is the effect of Carvistar 3.125 Tablet on the Kidneys?
Carvistar is completely safe for kidneys.
What is the effect of Carvistar 3.125 Tablet on the Liver?
Carvistar may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Carvistar 3.125 Tablet on the Heart?
Side effects of Carvistar rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Carvistar 3.125 Tablet unless your doctor advises you to do so -
Is this Carvistar 3.125 Tablet habit forming or addictive?
Carvistar 3.125 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Carvistar 3.125 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Carvistar 3.125 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Carvistar 3.125 Tablet in mental disorders is not effective.
Interaction between Food and Carvistar 3.125 Tablet
Carvistar 3.125 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Carvistar 3.125 Tablet
Consumption of alcohol and Carvistar 3.125 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)